Skip to content
10-Q

Quarterly Report

Elanco Animal Health Incorporated ELAN

0001739104-25-000071

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 496.86M sh
Shares Diluted Q3 2025 · Sep 30, 2025 496.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 501.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 497.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 496.9M sh
Capex Q3 2025 · Sep 30, 2025 $214M
Capex Q3 2025 · Sep 30, 2024 $100M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $452M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $364M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $505M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $468M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.75B
Stockholders Equity Q3 2025 · Jun 30, 2025 $6.78B
Stockholders Equity Q3 2025 · Mar 31, 2025 $6.35B
Stockholders Equity Q3 2025 · Dec 31, 2024 $6.1B
Stockholders Equity Q3 2025 · Sep 30, 2024 $6.52B
Stockholders Equity Q3 2025 · Jun 30, 2024 $5.94B
Stockholders Equity Q3 2025 · Mar 31, 2024 $6.06B
Stockholders Equity Q3 2025 · Dec 31, 2023 $6.22B
Current Liabilities Q3 2025 · Sep 30, 2025 $1.46B
Current Liabilities Q3 2025 · Dec 31, 2024 $1.32B
Total Liabilities Q3 2025 · Sep 30, 2025 $6.8B
Total Liabilities Q3 2025 · Dec 31, 2024 $6.52B
Current Assets Q3 2025 · Sep 30, 2025 $3.49B
Current Assets Q3 2025 · Dec 31, 2024 $3.22B
Total Assets Q3 2025 · Sep 30, 2025 $13.55B
Total Assets Q3 2025 · Dec 31, 2024 $12.61B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2025 $0.09
Eps Diluted Q3 2025 · Sep 30, 2024 $0.73
Eps Diluted Q3 2025 · Sep 30, 2024 $0.70
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2025 $0.09
Eps Basic Q3 2025 · Sep 30, 2024 $0.74
Eps Basic Q3 2025 · Sep 30, 2024 $0.70
Sga Expense Q3 2025 · Sep 30, 2025 $351M
Sga Expense Q3 2025 · Sep 30, 2025 $1.09B
Sga Expense Q3 2025 · Sep 30, 2024 $323M
Sga Expense Q3 2025 · Sep 30, 2024 $1.01B
Rd Expense Q3 2025 · Sep 30, 2025 $89M
Rd Expense Q3 2025 · Sep 30, 2025 $275M
Rd Expense Q3 2025 · Sep 30, 2024 $87M
Rd Expense Q3 2025 · Sep 30, 2024 $263M
Net Income Q3 2025 · Sep 30, 2025 −$34M
Net Income Q3 2025 · Sep 30, 2025 $44M
Net Income Q3 2025 · Jun 30, 2025 $11M
Net Income Q3 2025 · Mar 31, 2025 $67M
Net Income Q3 2025 · Sep 30, 2024 $364M
Net Income Q3 2025 · Sep 30, 2024 $346M
Net Income Q3 2025 · Jun 30, 2024 −$50M
Net Income Q3 2025 · Mar 31, 2024 $32M
Gross Profit Q3 2025 · Sep 30, 2025 $607M
Gross Profit Q3 2025 · Sep 30, 2025 $2B
Gross Profit Q3 2025 · Sep 30, 2024 $538M
Gross Profit Q3 2025 · Sep 30, 2024 $1.92B
Cost Of Revenue Q3 2025 · Sep 30, 2025 $530M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.57B
Cost Of Revenue Q3 2025 · Sep 30, 2024 $492M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.5B
Revenue Q3 2025 · Sep 30, 2025 $1.14B
Revenue Q3 2025 · Sep 30, 2025 $3.57B
Revenue Q3 2025 · Sep 30, 2024 $1.03B
Revenue Q3 2025 · Sep 30, 2024 $3.42B